| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities: | |||||||||||
Net income | |||||||||||
1,503,000 | 1,848,000 | 273,000 | 966,000 | 892,000 | 835,000 | 1,010,000 | 1,149,000 | 1,085,000 | 418,000 | 113,000 | -107,000 |
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
Deferred income taxes | |||||||||||
-352,000 | -35,000 | -181,000 | -9,000 | -27,000 | -44,000 | 161,000 | -10,000 | 75,000 | -278,000 | -256,000 | -430,000 |
Depreciation and amortization | |||||||||||
328,000 | 509,000 | 888,000 | 829,000 | 95,000 | 90,000 | 108,000 | 120,000 | 148,000 | 198,000 | 347,000 | 385,000 |
Provision for inventories | |||||||||||
6,000 | 6,000 | 33,000 | 42,000 | 43,000 | 39,000 | 33,000 | 13,000 | 8,000 | - | - | - |
Non-cash operating lease cost | |||||||||||
64,000 | 0 | 0 | - | - | - | - | - | - | - | - | - |
Loss on disposal of property and equipment | |||||||||||
- | - | - | - | - | - | 0 | -1,000 | -4,000 | -1,000 | -2,000 | -6,000 |
Amortization of capitalized software development costs and intellectual property licenses | |||||||||||
225,000 | 489,000 | 311,000 | 321,000 | 399,000 | 256,000 | 207,000 | 208,000 | 287,000 | 319,000 | 281,000 | 176,000 |
Loss on extinguishment of debt | |||||||||||
0 | 40,000 | 12,000 | 92,000 | 0 | 0 | - | - | - | - | - | - |
Amortization of debt discount and financing costs | |||||||||||
- | - | - | 21,000 | - | - | - | - | - | - | - | - |
Amortization of debt discount, financing costs, and non-cash write-off due to extinguishment of debts | |||||||||||
- | - | - | - | -7,000 | -7,000 | 1,000 | 0 | 0 | - | - | - |
Impairment of goodwill (see Note 9) | |||||||||||
- | - | - | - | - | - | - | - | 12,000 | 326,000 | 409,000 | 21,000 |
(Gain)/loss on auction rate securities classified as trading securities | |||||||||||
- | - | - | - | - | - | - | - | - | - | - | -7,000 |
Unrealized loss on ARS rights from UBS | |||||||||||
- | - | - | - | - | - | - | - | - | - | - | -2,000 |
Share-based compensation expense | |||||||||||
166,000 | 209,000 | 176,000 | 147,000 | 92,000 | 104,000 | 108,000 | 126,000 | 103,000 | 131,000 | 156,000 | 89,000 |
Unrealized gain on equity investment | |||||||||||
38,000 | 0 | 0 | - | - | - | - | - | - | - | - | - |
Other | |||||||||||
51,000 | 7,000 | 40,000 | 4,000 | 0 | 1,000 | - | - | - | - | - | - |
Excess tax benefits from stock awards | |||||||||||
- | - | - | - | - | - | 29,000 | 5,000 | 24,000 | 22,000 | 79,000 | 21,000 |
Changes in operating assets and liabilities: | |||||||||||
Accounts receivable, net | |||||||||||
-182,000 | 114,000 | 165,000 | -84,000 | 40,000 | 177,000 | -198,000 | 46,000 | -13,000 | -43,000 | -235,000 | 428,000 |
Inventories | |||||||||||
-7,000 | 5,000 | 26,000 | -32,000 | 54,000 | 2,000 | -6,000 | 75,000 | 42,000 | -124,000 | -21,000 | 20,000 |
Software development and intellectual property licenses | |||||||||||
275,000 | 372,000 | 301,000 | 362,000 | 350,000 | 349,000 | 268,000 | 301,000 | 254,000 | 313,000 | 308,000 | 181,000 |
Other assets | |||||||||||
-164,000 | 51,000 | 97,000 | 10,000 | -21,000 | -18,000 | 67,000 | -88,000 | 67,000 | -17,000 | 110,000 | 165,000 |
Deferred revenues | |||||||||||
-154,000 | -122,000 | 220,000 | -35,000 | -27,000 | 475,000 | -275,000 | 153,000 | -248,000 | 293,000 | 503,000 | 726,000 |
Accounts payable | |||||||||||
31,000 | -65,000 | 85,000 | -50,000 | -25,000 | -12,000 | 7,000 | -54,000 | 31,000 | 70,000 | -18,000 | 86,000 |
Accrued expenses and other liabilities | |||||||||||
-77,000 | -554,000 | 945,000 | 83,000 | 233,000 | 90,000 | 64,000 | -22,000 | -179,000 | 49,000 | -113,000 | 233,000 |
Net cash provided by operating activities | |||||||||||
1,831,000 | 1,790,000 | 2,213,000 | 2,155,000 | 1,259,000 | 1,331,000 | 1,264,000 | 1,345,000 | 952,000 | 1,376,000 | 1,183,000 | 379,000 |
Cash flows from investing activities: | |||||||||||
Proceeds from maturities of available-for-sale investments | |||||||||||
153,000 | 116,000 | 80,000 | 0 | 145,000 | 21,000 | 304,000 | 444,000 | 740,000 | - | - | - |
Purchases of available-for-sale investments | |||||||||||
65,000 | 209,000 | 135,000 | 0 | 145,000 | 0 | 26,000 | 503,000 | 417,000 | 800,000 | 425,000 | - |
Proceeds from auction rate securities called at par | |||||||||||
- | - | - | - | - | - | - | 10,000 | 10,000 | 519,000 | 44,000 | 0 |
Proceeds from sales of available-for-sale investments | |||||||||||
- | - | - | - | - | - | 98,000 | 0 | 0 | - | 2,000 | 0 |
Net proceeds from disposal of assets-restructuring (see Note 8) | |||||||||||
- | - | - | - | - | - | - | - | - | - | - | 9,000 |
Proceeds from sale of ARS classified as trading securities | |||||||||||
- | - | - | - | - | - | - | - | - | - | - | 0 |
Payments to Acquire Businesses, Net of Cash Acquired | |||||||||||
- | - | - | 4,586,000 | 46,000 | 0 | - | - | - | - | - | -1,120,000 |
Release (deposit) of cash in escrow | |||||||||||
- | - | - | - | 3,561,000 | 0 | -6,000 | 2,000 | -8,000 | -9,000 | -5,000 | -18,000 |
Release of cash in escrow | |||||||||||
- | - | - | - | - | - | 0 | - | 3,000 | 4,000 | 0 | 0 |
Acquisition of business (see Note 23) | |||||||||||
- | - | - | - | - | - | 0 | - | - | - | - | - |
Proceeds from maturities of auction rate securities classified as trading securities | |||||||||||
- | - | - | - | - | - | - | - | - | 61,000 | 0 | - |
Proceeds from auction rate securities called at par | |||||||||||
- | - | - | - | - | - | - | - | - | 0 | 0 | - |
Purchases of short-term investments | |||||||||||
- | - | - | - | - | - | - | - | - | - | - | 0 |
Capital expenditures | |||||||||||
116,000 | 131,000 | 155,000 | 136,000 | 111,000 | 107,000 | 74,000 | 73,000 | 72,000 | 97,000 | 69,000 | 46,000 |
Other investing activities | |||||||||||
-6,000 | 6,000 | -3,000 | 7,000 | -2,000 | -2,000 | - | - | - | - | - | - |
Net cash used in investing activities | |||||||||||
-22,000 | -230,000 | -207,000 | -4,729,000 | -3,716,000 | -84,000 | 308,000 | -124,000 | 266,000 | -312,000 | -443,000 | 1,101,000 |
Cash flows from financing activities: | |||||||||||
Proceeds from issuance of common stock to employees | |||||||||||
105,000 | 99,000 | 178,000 | 106,000 | 106,000 | 175,000 | 158,000 | 33,000 | 69,000 | 81,000 | 81,000 | 22,000 |
Tax payment related to net share settlements on restricted stock units | |||||||||||
59,000 | 94,000 | 56,000 | 115,000 | 83,000 | 66,000 | 49,000 | 16,000 | 15,000 | 8,000 | - | - |
Settlement of payable to Vivendi | |||||||||||
- | - | - | - | - | - | - | - | - | - | - | 79,000 |
Excess tax benefits from stock awards | |||||||||||
- | - | - | - | - | - | 29,000 | 5,000 | 24,000 | 22,000 | 79,000 | 21,000 |
Repurchase of common stock through tender offer | |||||||||||
- | - | - | - | - | - | - | - | - | - | - | 2,000 |
Return of capital to Vivendi | |||||||||||
- | - | - | - | - | - | - | - | - | - | - | 79,000 |
Issuance of additional common stock related to the Business Combination | |||||||||||
- | - | - | - | - | - | - | - | - | - | - | 1,731,000 |
Repurchase of common stock | |||||||||||
- | - | - | - | - | - | 5,830,000 | 315,000 | 692,000 | 959,000 | 1,109,000 | 126,000 |
Payments of Ordinary Dividends, Common Stock | |||||||||||
283,000 | 259,000 | 226,000 | 195,000 | 170,000 | 147,000 | 216,000 | 204,000 | 194,000 | 189,000 | 0 | 0 |
Proceeds from debt issuances, net of discounts | |||||||||||
0 | 0 | 3,741,000 | 6,878,000 | 0 | 0 | 4,750,000 | 0 | 0 | - | - | - |
Repayment of long-term debt | |||||||||||
0 | 1,740,000 | 4,251,000 | 6,104,000 | 250,000 | 375,000 | 6,000 | 0 | 0 | - | - | - |
Debt financing costs related to debt issuances | |||||||||||
- | - | - | - | - | 0 | 59,000 | 0 | 0 | - | - | - |
Premium payment for early redemption of note | |||||||||||
0 | 25,000 | 0 | 63,000 | 0 | 0 | - | - | - | - | - | - |
Proceeds received from shareholder settlement (see Note 19) | |||||||||||
- | - | - | - | 202,000 | - | - | - | - | - | - | - |
Other financing activities | |||||||||||
0 | -1,000 | -10,000 | -7,000 | -7,000 | 0 | 0 | - | - | - | - | - |
Net cash provided by financing activities | |||||||||||
-237,000 | -2,020,000 | -624,000 | 500,000 | -202,000 | -413,000 | -1,223,000 | -497,000 | -808,000 | -1,053,000 | -949,000 | 1,488,000 |
Effect of foreign exchange rate changes on cash and cash equivalents | |||||||||||
-3,000 | -31,000 | 76,000 | -56,000 | -366,000 | -396,000 | 102,000 | 70,000 | -57,000 | 33,000 | 19,000 | -72,000 |
Net increase in cash and cash equivalents and restricted cash | |||||||||||
1,569,000 | -491,000 | 1,458,000 | -2,130,000 | -3,025,000 | 438,000 | 451,000 | 794,000 | 353,000 | 44,000 | -190,000 | 2,896,000 |